Verve Therapeutics Inc (VERV)
6.41
+0.26
(+4.23%)
USD |
NASDAQ |
May 03, 16:00
6.40
-0.01
(-0.16%)
After-Hours: 20:00
Verve Therapeutics EPS Diluted (Quarterly): -0.69 for Dec. 31, 2023
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -0.69 |
September 30, 2023 | -0.72 |
June 30, 2023 | -0.87 |
March 31, 2023 | -0.84 |
December 31, 2022 | -0.67 |
September 30, 2022 | -0.79 |
June 30, 2022 | -0.84 |
March 31, 2022 | -0.62 |
Date | Value |
---|---|
December 31, 2021 | -0.65 |
September 30, 2021 | -0.47 |
June 30, 2021 | -1.105 |
March 31, 2021 | -0.3027 |
December 31, 2020 | -0.8066 |
September 30, 2020 | -0.3082 |
June 30, 2020 | -0.2598 |
March 31, 2020 | -0.1921 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-1.105
Minimum
Jun 2021
-0.1921
Maximum
Mar 2020
-0.6334
Average
-0.68
Median
EPS Diluted (Quarterly) Benchmarks
Acorda Therapeutics Inc | -175.32 |
Eli Lilly and Co | 2.48 |
Beam Therapeutics Inc | 1.73 |
Intellia Therapeutics Inc | -1.46 |
Gritstone Bio Inc | -0.26 |
EPS Diluted (Quarterly) Related Metrics
Net Income (Quarterly) | -48.35M |
Revenue (Quarterly) | 5.144M |
Total Expenses (Quarterly) | 59.09M |
Enterprise Value | -87.95M |
Profit Margin (Quarterly) | -940.0% |
Earnings Yield | -48.67% |
Normalized Earnings Yield | -48.67 |